Hi all,
I have a basic question that I’m finding it hard to obtain an answer for, my apologies if I’m a nuffy.
Ragarding development of a new drug in clinical development stage, what are the benefits and limitations of mono therapy trials and conversely combination therapy trials with already approved SOC drugs?
Hi all,I have a basic question that I’m finding it hard to...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.2¢ | $1.975M | 36.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 4400559 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1340583 | 5 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |